Charles River Laboratories International (CRL) Operating Income (2016 - 2025)
Historic Operating Income for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $133.8 million.
- Charles River Laboratories International's Operating Income rose 1396.36% to $133.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $140.9 million, marking a year-over-year decrease of 7330.93%. This contributed to the annual value of $227.3 million for FY2024, which is 6316.84% down from last year.
- Latest data reveals that Charles River Laboratories International reported Operating Income of $133.8 million as of Q3 2025, which was up 1396.36% from $100.1 million recorded in Q2 2025.
- Charles River Laboratories International's 5-year Operating Income high stood at $187.4 million for Q2 2022, and its period low was -$167.7 million during Q4 2024.
- Over the past 5 years, Charles River Laboratories International's median Operating Income value was $148.8 million (recorded in 2022), while the average stood at $126.0 million.
- In the last 5 years, Charles River Laboratories International's Operating Income soared by 7917.62% in 2021 and then crashed by 22615.44% in 2024.
- Quarter analysis of 5 years shows Charles River Laboratories International's Operating Income stood at $172.8 million in 2021, then dropped by 5.21% to $163.8 million in 2022, then dropped by 18.86% to $132.9 million in 2023, then tumbled by 226.15% to -$167.7 million in 2024, then surged by 179.79% to $133.8 million in 2025.
- Its Operating Income stands at $133.8 million for Q3 2025, versus $100.1 million for Q2 2025 and $74.7 million for Q1 2025.